DK1073436T3 - Forbedret fremgangsmåde til udryddelse af helicobacter pylori - Google Patents
Forbedret fremgangsmåde til udryddelse af helicobacter pyloriInfo
- Publication number
- DK1073436T3 DK1073436T3 DK99915381T DK99915381T DK1073436T3 DK 1073436 T3 DK1073436 T3 DK 1073436T3 DK 99915381 T DK99915381 T DK 99915381T DK 99915381 T DK99915381 T DK 99915381T DK 1073436 T3 DK1073436 T3 DK 1073436T3
- Authority
- DK
- Denmark
- Prior art keywords
- helicobacter pylori
- eradication
- improved method
- antibiotic
- prevention
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 230000008029 eradication Effects 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 208000010643 digestive system disease Diseases 0.000 abstract 1
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- ATEBXHFBFRCZMA-VXTBVIBXSA-N rifabutin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC(=C2N3)C(=O)C=4C(O)=C5C)C)OC)C5=C1C=4C2=NC13CCN(CC(C)C)CC1 ATEBXHFBFRCZMA-VXTBVIBXSA-N 0.000 abstract 1
- 229960000885 rifabutin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP3253A AUPP325398A0 (en) | 1998-04-30 | 1998-04-30 | Improved method for eradicating h. pylori |
| PCT/AU1999/000321 WO1999056749A1 (en) | 1998-04-30 | 1999-04-30 | IMPROVED METHOD FOR ERADICATION OF $i(HELICOBACTER PYLORI) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1073436T3 true DK1073436T3 (da) | 2007-03-19 |
Family
ID=3807506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99915381T DK1073436T3 (da) | 1998-04-30 | 1999-04-30 | Forbedret fremgangsmåde til udryddelse af helicobacter pylori |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6489317B1 (da) |
| EP (1) | EP1073436B1 (da) |
| AT (1) | ATE344664T1 (da) |
| AU (1) | AUPP325398A0 (da) |
| CA (1) | CA2330424C (da) |
| CY (1) | CY1106449T1 (da) |
| DE (1) | DE69933925T2 (da) |
| DK (1) | DK1073436T3 (da) |
| ES (1) | ES2276516T3 (da) |
| PT (1) | PT1073436E (da) |
| WO (1) | WO1999056749A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| US20070092502A1 (en) * | 2005-09-01 | 2007-04-26 | Allergan, Inc. | Method of Treating Glaucoma |
| US8785402B2 (en) * | 2009-07-31 | 2014-07-22 | Academia Sinica | Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions |
| US9511080B2 (en) * | 2009-12-31 | 2016-12-06 | Okada Medical Services Pty Ltd | Okadaella gastrococcus and cancer |
| CN110200954A (zh) | 2010-12-13 | 2019-09-06 | 萨利克斯药品有限公司 | 胃和结肠的配制剂及其制备和使用方法 |
| HUE043852T2 (hu) | 2012-07-27 | 2019-09-30 | Redhill Biopharma Ltd | A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei |
| CA2900763C (en) * | 2013-02-13 | 2021-04-06 | Reza Fathi | Pharmaceutical compositions for the treatment of helicobacter pylori |
| US11878011B2 (en) | 2020-05-07 | 2024-01-23 | Redhill Biopharma Ltd. | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index |
| CN117398360B (zh) * | 2023-12-14 | 2024-03-15 | 山东齐都药业有限公司 | 治疗幽门螺杆菌的复方制剂胶囊及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513551D0 (en) | 1995-07-04 | 1995-09-06 | Pharmacia Spa | Anti-bacterial synergistic composition |
| ATE389417T1 (de) * | 1997-04-01 | 2008-04-15 | Borody Thomas J | Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen |
-
1998
- 1998-04-30 AU AUPP3253A patent/AUPP325398A0/en not_active Abandoned
-
1999
- 1999-04-30 DE DE69933925T patent/DE69933925T2/de not_active Expired - Lifetime
- 1999-04-30 PT PT99915381T patent/PT1073436E/pt unknown
- 1999-04-30 WO PCT/AU1999/000321 patent/WO1999056749A1/en active IP Right Grant
- 1999-04-30 DK DK99915381T patent/DK1073436T3/da active
- 1999-04-30 EP EP99915381A patent/EP1073436B1/en not_active Expired - Lifetime
- 1999-04-30 US US09/673,631 patent/US6489317B1/en not_active Expired - Lifetime
- 1999-04-30 ES ES99915381T patent/ES2276516T3/es not_active Expired - Lifetime
- 1999-04-30 CA CA002330424A patent/CA2330424C/en not_active Expired - Lifetime
- 1999-04-30 AT AT99915381T patent/ATE344664T1/de active
-
2007
- 2007-02-05 CY CY20071100155T patent/CY1106449T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1073436A1 (en) | 2001-02-07 |
| ES2276516T3 (es) | 2007-06-16 |
| CY1106449T1 (el) | 2012-01-25 |
| DE69933925T2 (de) | 2007-09-13 |
| EP1073436A4 (en) | 2001-08-08 |
| PT1073436E (pt) | 2007-01-31 |
| DE69933925D1 (de) | 2006-12-21 |
| AUPP325398A0 (en) | 1998-05-21 |
| CA2330424A1 (en) | 1999-11-11 |
| CA2330424C (en) | 2007-10-30 |
| ATE344664T1 (de) | 2006-11-15 |
| US6489317B1 (en) | 2002-12-03 |
| EP1073436B1 (en) | 2006-11-08 |
| WO1999056749A1 (en) | 1999-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
| DK1033981T3 (da) | Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet | |
| NO20012774D0 (no) | Preparat og metode hvor det gjöres bruk av eteriske planteoljer | |
| DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
| TR200002855T2 (tr) | Raloksifenin solunum yolu ile veya burundan uygulanması. | |
| ES2194536T3 (es) | Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos. | |
| GB0008269D0 (en) | Combination chemotherapy | |
| BR9910180A (pt) | Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico | |
| PT705100E (pt) | Guanidinas substituidas terapeuticas | |
| BR9914940A (pt) | Método para aperfeiçoar a farmacocinética de tipranavir | |
| CY1106449T1 (el) | Βελτιωμενη μεθοδος για εκριζωση του helicobacter pylori | |
| EP0932613A4 (en) | EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS | |
| NO990833D0 (no) | Farmas°ytiske forbindelser | |
| DK0847755T3 (da) | Anvendelse af en ekstrakt af cimicifuga racemosa | |
| DE69729183D1 (de) | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen | |
| DK0946157T3 (da) | Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte | |
| HUP9904073A2 (hu) | Bizmutot és nemszteroid gyulladásgátló hatóanyagot tartalmazó készítmények gasztrointesztinális rendellenességek kezelésére | |
| DK1124566T3 (da) | Ikke-fermenteret osmotisk laxativ til behandling og forebyggelse af colorectale cancere | |
| AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
| DE69626544D1 (de) | Arzneistoffe | |
| AU5434899A (en) | Cancer treatment | |
| PT1313500E (pt) | Associacoes de dalfopristina/quinupristina com o cefpirome | |
| TW200500073A (en) | Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof | |
| IT1304852B1 (it) | Miscela di piante medicinali per la prevenzione e la cura delleemorroidi. | |
| DZ2949A1 (fr) | Compositions pharmaceutiques de celecoxib, leurs procédés de préparation et procédés de traitement les utilisant. |